| Issue Date | Title | Author(s) | Citation |
| 2008 | A 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasome | Davey, Ross; Stordal, Britta; Northern Clinical School: Medicine; Medicine Faculty Office | A 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasome, IUBMB Life, vol.60,(3),2008,pp 180-184 |
| 2009 | ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair | Davey, Ross; Stordal, Britta; Northern Clinical School: Medicine; Medicine Faculty Office | ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair, Cancer Chemotherapy and Pharmacology, vol.63,(4),2009,pp 661-672 |
| 2007 | Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review | Davey, Ross; Pavlakis, Nick; Stordal, Britta; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty Office | Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review, Cancer Treatment Reviews, vol.33,(N/A),2007,pp 347-357 |
| 2005 | Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells | Davey, Ross; Stordal, Britta; Davey, M. W.; Physics; Medicine Faculty Office | Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells, Cancer Chemotherapy and Pharmacology, vol.58,(2),2005,pp 256-265 |
| 2009 | Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrest | Davey, Ross; Stordal, Britta; Northern Clinical School: Medicine; Medicine Faculty Office | Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrest in Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, Humana Press, 2009, pp. 171-176 |
| 2006 | Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance. | Davey, Ross; Stordal, Britta; Peters, Greg; Physics; Medicine Faculty Office | Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance., Genes Chromosomes & Cancer, vol.45,(12),2006,pp 1094-1105 |
| 2009 | A systematic alalysis of oxaliplatin or paclitaxel salvage chemotherapy | Davey, Ross; Pavlakis, Nick; Stordal, Britta; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty Office | A systematic alalysis of oxaliplatin or paclitaxel salvage chemotherapy in Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, Humana Press, 2009, pp. 225-230 |
| 2009 | A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1. | Davey, Ross; Stordal, Britta; Northern Clinical School: Medicine | A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1., Current Cancer Drug Targets, vol.9, 3,pp 354-365 |
| 2007 | A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship | Davey, Ross; Pavlakis, Nick; Stordal, Britta; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty Office | A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship, Cancer Treatment Reviews, vol.33,(8),2007,pp 688-703 |